Updates on Bioequivalence (BE) Webpage (August 2018): Immediate Release Solid Oral Dosage Form

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

1. Application Forms and Checklist

i) Application For Biopharmaceutics Classification System (BCS) Biowaiver

ii) Application For A Biowaiver: Additional Strength

iii) Bioequivalence Study Report Submission Checklist

 

2. New Active Ingredients Listed in the Product Comparator List

No

Active Ingredient

Comparators

Manufacturer

1

Co-Dergocrine Mesylate

Hydergine Tablet 1mg
MAL19870102A

Hydergine Tablet 1.5mg
MAL19870106A

Hydergine Tablet 4.5mg
MAL19870111A

Novartis Farma S.P.A., Italy

 

Novartis Pharma AG, Switzerland

 

Novartis Pharma AG, Switzerland

2

Fimasartan Potassium Trihydrate

Kanarb Film-Coated Tablet 60mg
MAL8026063ARZ

Kanarb Film-Coated Tablet 120mg
MAL18026065ARZ

Boryung Pharmaceutical Co Ltd, South Korea

3

Ibuprofen Lysine

Nurofen Express 342mg Caplet
MAL13085058AZ

Nurofen Express 684mg Caplet
MAL13085061AZ

Reckitt Benckiser Healthcare International, United Kingdom

Reckitt Benckiser Healthcare International, United Kingdom

4

Piroxicam-B-Cyclodextrin

Brexin Tablet
MAL19992991AZ

Chiesi Farmaceutici S.P.A., Italy

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3. Additional Comparators Added to the Existing Comparator List

No

Active Ingredient

Additional Comparators

Manufacturer

1

Fenofibrate

Lipanthyl Capsule 300mg
(MAL19930138A)

Labs Fournier, France

2

Ibuprofen

Nurofen Express 200mg Liquid Capsules
(MAL18016015ACRZ)

Nurofen Express 400mg Liquid Capsules
(MAL18016016ACRZ)

Patheon Softgels B.V., Netherlands

 

Patheon Softgels B.V., Netherlands

3

Pravastatin

Apo-Pravastatin 20mg Tablet
(MAL20040229ARZ)

Apo-Pravastatin 40mg Tablet
(MAL06030825AZ)

Apotex Inc, Canada

 

Apotex Inc, Canada

4

Thioguanine

Lanvis Tablets 40mg
(MAL13065045ACZ)

Excella GmbH & Co. Kg, Germany

 

4. Additional Manufacturing Site added to Existing Comparator List

No

Active Ingredient

Comparator List

Product Name

Additional Manufacturing Site

1

Amlodipine

6th

Norvasc Tablet 5mg

Norvasc Tablet 10mg

Pfizer Pharmaceuticals LLC, United States

2

Atazanavir

ARV

Reyataz Capsule 100mg

Reyataz Capsule 150mg

Reyataz Capsule 200mg

AstraZeneca Pharmaceuticals LP, United States

3

Drospirenone 3mg + Ethinyl Estradiol 30mcg

FDC

Yasmin Tablet

Bayer Weimar GmbH und Co. KG, Germany

4

Entecavir

BE

Baraclude Tablet 0.5mg

AstraZeneca Pharmaceuticals LP, United States

5

Naltrexone Hydrochloride

BE

Revia Tablet 50mg

Bristol-Myers Squibb Australia Pty Ltd., Australia

Teva Canada Limited, Canada

6

Paroxetine

9th

Seroxat 20mg Tablet

S.C Europharm S.A, Romania

GlaxoSmithKline Pharmaceuticals S.A, Poland

 

5. Active pharmaceutical ingredient added to “Biowaivers granted based on unavailability/ inaccessibility of comparator/innovator product (List B)

iv) Dicyclomine HCl

 

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA